Ledyard National Bank’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-8,738
Closed -$2.63M 304
2018
Q4
$2.63M Buy
8,738
+671
+8% +$214K 0.35% 91
2018
Q3
$2.85M Sell
8,067
-11
-0.1% -$3.79K 0.32% 95
2018
Q2
$2.35M Buy
8,078
+32
+0.4% +$9K 0.28% 104
2018
Q1
$2.2M Buy
8,046
+323
+4% +$100K 0.27% 106
2017
Q4
$2.46M Sell
7,723
-262
-3% -$84.1K 0.3% 98
2017
Q3
$2.5M Buy
7,985
+129
+2% +$38.2K 0.33% 96
2017
Q2
$2.13M Buy
7,856
+292
+4% +$77.2K 0.31% 95
2017
Q1
$2.07M Sell
7,564
-268
-3% -$75.8K 0.31% 92
2016
Q4
$2.22M Sell
7,832
-1,486
-16% -$440K 0.39% 87
2016
Q3
$2.92M Sell
9,318
-182
-2% -$53.9K 0.52% 70
2016
Q2
$2.3M Sell
9,500
-312
-3% -$82.2K 0.41% 80
2016
Q1
$2.55M Buy
9,812
+62
+0.6% +$16.4K 0.45% 82
2015
Q4
$2.99M Sell
9,750
-1,428
-13% -$410K 0.54% 67
2015
Q3
$3.26M Buy
11,178
+10,727
+2,378% +$3.54M 0.63% 58
2015
Q2
$183K Buy
451
+9
+2% +$3.61K 0.03% 181
2015
Q1
$187K Hold
442
0.03% 176
2014
Q4
$150K Hold
442
0.03% 191
2014
Q3
$146K Hold
442
0.03% 180
2014
Q2
$139K Sell
442
-100
-18% -$30.1K 0.02% 188
2014
Q1
$166K Hold
542
0.03% 167
2013
Q4
$152K Buy
542
+42
+8% +$10.9K 0.03% 166
2013
Q3
$120K Hold
500
0.02% 171
2013
Q2
$108K Buy
+500
New +$107K 0.02% 174

Other funds holding BIIB

Ledyard National Bank's BIIB Position: Q1 2019 in Review

Ledyard National Bank sold out of Biogen (BIIB) in Q1 2019, closing a stake of 8,738 shares — an estimated $2.63M sold.

Ledyard National Bank first reported a position in BIIB in Q2 2013 and held it in 23 quarters. The position peaked at $3.26M in Q3 2015. 1,085 funds tracked by Wall St. Rank hold BIIB as of Q1 2019.

  • Ledyard National Bank reported no remaining Biogen position as of Q1 2019 after selling out during the quarter.
  • Ledyard National Bank sold 8,738 Biogen shares in Q1 2019, an estimated $2.63M.
  • Ledyard National Bank first reported a position in Biogen in Q2 2013 and held it in 23 quarters.
  • Ledyard National Bank's Biogen position peaked at $3.26M in Q3 2015.
  • 1,085 funds tracked by Wall St. Rank held Biogen as of Q1 2019.

Based on Ledyard National Bank's 13F filing for Q1 2019, filed 12 Apr 2019.